Valuation: Orgenesis Inc.

Market Cap 983K 850K 794K 728K 1.37M 93.54M 1.39M 9.31M 3.66M 46.88M 3.69M 3.61M 155M P/E 2023
-0.26x
P/E 2024 -0.17x
Enterprise Value 19.16M 16.58M 15.48M 14.2M 26.71M 1.82B 27.13M 182M 71.29M 914M 71.96M 70.39M 3.02B EV / Sales 2023
71.2x
EV / Sales 2024 27x
Free-Float
52.06%
Yield 2023 *
-
Yield 2024 -
1 day-16.67%
1 week-12.50%
Current month-50.70%
1 month-12.50%
3 months-45.74%
6 months-32.26%
Current year+133.33%
1 week 0.02
Extreme 0.02
0.42
1 month 0
Extreme 0.001
0.71
Current year 0
Extreme 0.001
0.84
1 year 0
Extreme 0.001
1
3 years 0
Extreme 0.0001
11.7
5 years 0
Extreme 0.0001
54.8
10 years 0
Extreme 0.0001
168
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 72 02/02/2012
Chief Executive Officer 57 24/12/2013
Director of Finance/CFO 51 10/03/2026
Director TitleAgeSince
Chairman 57 14/08/2014
Director/Board Member 64 08/07/2024
Director/Board Member 47 28/10/2024
Date Insider Type Main position Quantity % Market Cap.
5/3/25 Other 1,200,000 23.2142%
12/12/24 Free

Director

1,500 0.0290%
12/12/24 Free

Director

1,835 0.0355%
Change 5-day change 1-year change 3-year change Capi.($)
-16.67%-12.50%+1,490.91%-96.70% 3.43M
-0.14%+2.00%-18.36%-0.59% 187B
+1.44%+2.07%-4.47%+2.88% 110B
-1.40%+2.93%+15.11%+71.75% 62.02B
+0.65%+7.55%+37.26%+57.59% 53.79B
-0.12%+6.79%-5.77%-35.74% 48.79B
+2.08%+1.56%+10.93%-29.94% 31.33B
+2.09%-10.31% - - 30.27B
+1.57%+3.85%+47.20%-6.50% 24.53B
+2.45%+3.97%+0.52%+4.99% 22.59B
Average -1.00%+2.18%+174.81%-3.58% 57.01B
Weighted average by Cap. +0.06%+2.55%+0.47%+9.31%

Financials

2023 2024
Net sales 530K 458K 428K 393K 739K 50.44M 750K 5.02M 1.97M 25.28M 1.99M 1.95M 83.58M 1.03M 895K 836K 767K 1.44M 98.5M 1.47M 9.81M 3.85M 49.37M 3.89M 3.8M 163M
Net income -55.36M -47.89M -44.72M -41.02M -77.16M -5.27B -78.39M -525M -206M -2.64B -208M -203M -8.73B -48.16M -41.66M -38.91M -35.69M -67.13M -4.58B -68.2M -456M -179M -2.3B -181M -177M -7.6B
Net Debt 21.78M 18.84M 17.6M 16.14M 30.36M 2.07B 30.84M 206M 81.03M 1.04B 81.8M 80.01M 3.44B 18.18M 15.73M 14.69M 13.47M 25.34M 1.73B 25.74M 172M 67.63M 867M 68.27M 66.78M 2.87B
Logo Orgenesis Inc.
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.
Employees
77
Date Price Change Volume
06/08/26 US$0.3500 -16.67% 100
05/08/26 US$0.4200 +5.00% 100
04/08/26 US$0.4000 +33.33% 110
03/08/26 US$0.3000 -57.75% 951
31/07/26 US$0.7100 +77.50% 100
  1. Stock Market
  2. Stocks
  3. ORGS Stock